Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders

NCT00845988 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Bipolar Disorders
Metabolic Complication

Interventions

DRUG: aripiprazole

Sponsor

Seoul National University Hospital

Collaborators

[object Object]